CD44 and prostate carcinoma: CD44 is recognized as the principal receptor for hyaluronic acid (HA) [7] and CD44-HA interactions have been demonstrated to affect many physiological and disease processes including promoting keratinocyte activity, improving abnormal epidermal function and melanoma and prostate cancer development [8–11].